|
|
.
NPI Detail
NPI: 1871543215
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
300 XXXXXXX XX
STANFORD, CA 943052200
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1871543215*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXXX
|
$XXXXXX.X
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXXX.XX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J1442
|
Inj filgrastim excl biosimil
|
XXXXXX
|
$XXXXXX.XX
|
| J2795
|
Ropivacaine hcl injection
|
XXXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXXX
|
$XXXXXX.XX
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J1453
|
Fosaprepitant injection
|
XXXXXX
|
$XXXXX.XX
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXXX
|
$XXXXXX.XX
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXXX
|
-
|
| J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXXX
|
$XXXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXXX
|
-
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXXX
|
$XXXXXXX.XX
|
| J3262
|
Tocilizumab injection
|
XXXXXX
|
$XXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J3111
|
Inj. romosozumab-aqqg 1 mg
|
XXXXXX
|
$XXXXXX.XX
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXXX
|
$XXXXXX.XX
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
| J1569
|
Gammagard liquid injection
|
XXXXXX
|
$XXXXXXX.XX
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J2001
|
Lidocaine injection
|
XXXXX
|
-
|
| J0885
|
Epoetin alfa, non-esrd
|
XXXXX
|
$XXXXXX.XX
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9035
|
Bevacizumab injection
|
XXXXX
|
$XXXXXXX.XX
|
| J9312
|
Inj., rituximab, 10 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J0485
|
Belatacept injection
|
XXXXX
|
$XXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J9171
|
Docetaxel injection
|
XXXXX
|
-
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXXX
|
$XXXXXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
